Key facts
- It has raised $1.2M; the latest was Angel (individual) ($1.2M) in Oct 2025.
- Notable investors include AngelLoop, Brisbane Economic Development Agency, Tech Ready Women.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Ketim Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Ketim Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ketim Technologies
Developer of a postpartum depression biomarker test designed for mental health disorders. The company uses a proprietary dataset, analytical platform and pipeline to develop a blood-based objective clinical test for postpartum depression, enabling healthcare providers to achieve timely and targeted interventions that can significantly improve outcomes for mothers and their families.
- Sector
- Healthcare
- HQ
- Brisbane, Australia
- Founded
- 2023
- Employees
- 9
- Website
- ketim.com.au/
- Ownership
- Privately Held (backing)
Ketim Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ketim Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ketim Technologies in its N-PORT filings yet. We sweep new filings monthly.